Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial

BACKGROUND: Female sex is an independent risk factor for stroke and systemic embolic events in patients with atrial fibrillation. This study aimed to examine the efficacy and safety profile of edoxaban in women versus men. METHODS: The ENGAGE AF-TIMI 48 trial (Effective Anticoagulation with Factor X...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Circulation
Autores principales: Zelniker, Thomas A., Ardissino, Maddalena, Andreotti, Felicita, O’Donoghue, Michelle L., Yin, Ophelia, Park, Jeong-Gun, Murphy, Sabina A., Ruff, Christian T., Lanz, Hans J., Antman, Elliott M., Braunwald, Eugene, Giugliano, Robert P., Merlini, Piera Angelica
Formato: Artigo
Lenguaje:Inglês
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Research Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7884089/
https://ncbi.nlm.nih.gov/pubmed/33587659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.120.052216
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares